Emily Spencer, PA
Medical · Frankfort, KYNPI 1700828720
Payments from drug & device makers
Across 99 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$323
- Lilly USA, LLC$273
- Boehringer Ingelheim$231
- Novo Nordisk$168
- AbbVie$79
- AstraZeneca$78
- plus $527 from 22 others
What the payments were for
- Food & beverage$1,677100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 20 | $323 |
| Lilly USA, LLC | 12 | $273 |
| Boehringer Ingelheim | 16 | $231 |
| Novo Nordisk | 10 | $168 |
| AbbVie | 4 | $79 |
| AstraZeneca | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Amgen | 2 | $37 |
| Inogen, Inc. | 2 | $32 |
| Bayer | 2 | $32 |
| Antares Pharma, Inc. | 2 | $32 |
| GSK | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,677 in reported general payments places this provider in the 60th percentile of 222 medical providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 30 | $36,838 |
| JanuviaSitagliptin Phosphate | 30 | $33,123 |
| OzempicSemaglutide | 25 | $31,803 |
| EliquisApixaban | 18 | $29,729 |
| TrulicityDulaglutide | 11 | $24,802 |
| JardianceEmpagliflozin | 13 | $12,921 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,041 |
| LinzessLinaclotide | 12 | $6,837 |
| InvokanaCanagliflozin | 13 | $6,831 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $6,352 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $6,310 |
| DuleraMometasone/Formoterol | 13 | $4,718 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,830 |
| Levothyroxine Sodium | 273 | $3,087 |
| Aripiprazole | 17 | $2,429 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $273 | $61,64041 claims |
| Novo NordiskOzempic | $168 | $31,80325 claims |
| PfizerEliquis | $15 | $29,72918 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $29 | $18,18040 claims |
| Boehringer IngelheimJardiance | $231 | $12,92113 claims |
| AbbVieLinzess, Synthroid | $79 | $8,79158 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 222 medical providers in Kentucky.
Other medical in Frankfort
- Danny ThackerFrankfort$11K
- Tonya CohornFrankfort$5K
- Autumn BallardFrankfort$5K
- Brittany DennistonFrankfort$5K
- Mikal BaileyPaducah$84K
- Kyle HeraldBowling Green$65K
- Chasity HesterLexington$16K
- Alexandra HuettLouisville$13K
- Jessica FrizzellPaducah$10K
- Terry SmithHazard$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.